HOLLAND & KNIGHT LLP

Lobbying for VIATRIS INC · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 11, 2025

Lobbying activity 1

Pharmacy

Safe Act of 2025; Supply Chain Issues; E-labeling; Inflation Reduction Act Implementation; Improving Generic Drug Access; PEPFAR; Drug Shortages; Medicaid Generics Penalty.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.